Zepp Health Co. (NYSE:ZEPP) Short Interest Update

Zepp Health Co. (NYSE:ZEPP - Get Free Report) was the target of a significant drop in short interest in March. As of March 15th, there was short interest totalling 2,200 shares, a drop of 46.3% from the February 29th total of 4,100 shares. Based on an average daily volume of 72,400 shares, the short-interest ratio is presently 0.0 days.

Wall Street Analyst Weigh In

Separately, Fundamental Research set a $4.96 price target on Zepp Health and gave the stock a "buy" rating in a research note on Tuesday.

Check Out Our Latest Research Report on Zepp Health

Hedge Funds Weigh In On Zepp Health

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Envestnet Asset Management Inc. bought a new position in Zepp Health in the 1st quarter worth approximately $49,000. Citadel Advisors LLC bought a new position in Zepp Health in the 3rd quarter worth approximately $30,000. Virtu Financial LLC bought a new position in Zepp Health in the 4th quarter worth approximately $33,000. Rhumbline Advisers grew its holdings in Zepp Health by 791.3% in the 3rd quarter. Rhumbline Advisers now owns 30,215 shares of the company's stock worth $35,000 after buying an additional 26,825 shares in the last quarter. Finally, Renaissance Technologies LLC bought a new position in Zepp Health in the 1st quarter worth approximately $107,000. 52.61% of the stock is currently owned by institutional investors and hedge funds.


Zepp Health Stock Performance

ZEPP stock traded down $0.02 during midday trading on Thursday, reaching $1.01. The company had a trading volume of 56,957 shares, compared to its average volume of 73,712. The company has a quick ratio of 1.49, a current ratio of 2.04 and a debt-to-equity ratio of 0.34. The stock has a 50 day moving average price of $1.23 and a 200 day moving average price of $1.27. Zepp Health has a fifty-two week low of $0.90 and a fifty-two week high of $2.10. The firm has a market capitalization of $61.95 million, a PE ratio of -2.06 and a beta of 0.81.

Zepp Health Company Profile

(Get Free Report)

Zepp Health Corporation operates as a smart wearable and health technology company worldwide. It empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura. The company through its proprietary Zepp Digital Management Platform, which includes the Zepp OS, AI chips, biometric sensors, and data algorithms, delivers cloud-based 24/7 actionable insights and guidance to help users attain wellness goals.

See Also

Should you invest $1,000 in Zepp Health right now?

Before you consider Zepp Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Zepp Health wasn't on the list.

While Zepp Health currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Featured Articles and Offers

Search Headlines: